Clinical Trial Update: Treatment of Eosinophilic Chronic Rhinosinusitis Utilizing Betamethasone Dipropionate Nasal Cream [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 trial evaluating betamethasone dipropionate nasal cream for eosinophilic chronic rhinosinusitis has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Eosinophilic Chronic Rhinosinusitis
• Rhinosinusitis

Drugs mentioned

• Betamethasone Dipropionate Nasal Cream (betamethasone dipropionate)

Snippet

Sponsor: Oticara Australia PTY LTD | Conditions: Chronic Rhinosinusitis (Diagnosis) | Phase 1, Phase 2 | Status: TERMINATED